BioAge Labs Inc. (BIOA)
NASDAQ: BIOAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
BIOA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $287.31M
- EPS (TTM)
- -$2.39
- Dividend yield
- None
- 52-week range
- 5.04 – 25.96
- Day range
- 6.20 – 6.68
- Volume / Avg
- 799.45K / 915.59K
- Beta
- —
- Shares outstanding
- 45.90M
- Next earnings
- Nov 5, 2026
52-week range
BIOA stock today
Shares of BioAge Labs (BIOA) finished lower on Oct 7 at $6.26, a drop of 0.48% or $0.03 per share, versus the S&P 500's 0.22% decline. Shares are 75.9% below their 52-week high of $25.96, set on Jul 6, 2026 and 24.2% above the 52-week low of $5.04, near the bottom of the past year's range. BIOA is down 52.7% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 11.8%.
BioAge Labs has posted a net loss over the last twelve months (EPS of -$2.39), so its P/E ratio is not meaningful. BioAge Labs's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About BioAge Labs
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- Emeryville, CA
- IPO year
- 2024
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.66
BioAge Labs peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ABEOAbeona Therapeutics Inc. | 5.08 | +1.40% | $290.49M | vs BIOA |
| LRMRLarimar Therapeutics Inc. | 2.75 | -1.08% | $285.68M | vs BIOA |
| CATXPerspective Therapeutics Inc. | 2.46 | +4.24% | $280.81M | vs BIOA |
| FULCFulcrum Therapeutics Inc. | 3.67 | -0.54% | $280.01M | vs BIOA |
| RCKTRocket Pharmaceuticals Inc. | 2.54 | +2.22% | $278.28M | vs BIOA |
| INDPIndaptus Therapeutics Inc. | 2.26 | -12.74% | $301.13M | vs BIOA |
| BBOTBridgeBio Oncology Therapeutics Inc. | 3.44 | -1.71% | $275.80M | vs BIOA |
| VNDAVanda Pharmaceuticals Inc. | 4.56 | +0.89% | $275.71M | vs BIOA |
Indexes, lists and sector
BioAge Labs stock FAQ
What is BioAge Labs's stock price today?
BIOA last traded at $6.26 as of Oct 7, 4:00 PM EDT, down 0.48% on the day. Prices are delayed at least 15 minutes.
When is BioAge Labs's next earnings date?
BioAge Labs is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.66.
What is the BIOA 52-week high?
The 52-week high for BIOA is $25.96 and the 52-week low is $5.04. The stock is currently 75.9% below its high.